BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20157412)

  • 1. Differential expression of stem cell markers and vascular endothelial growth factor in human retinoblastoma tissue.
    Kim M; Kim JH; Kim JH; Kim DH; Yu YS
    Korean J Ophthalmol; 2010 Feb; 24(1):35-9. PubMed ID: 20157412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell markers: ABCG2 and MCM2 expression in retinoblastoma.
    Mohan A; Kandalam M; Ramkumar HL; Gopal L; Krishnakumar S
    Br J Ophthalmol; 2006 Jul; 90(7):889-93. PubMed ID: 16556617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Angiogenic Factors in Invasive Retinoblastoma Tumors Is Associated With Increase in Tumor Cells Expressing Stem Cell Marker Sox2.
    Garcia JR; Gombos DS; Prospero CM; Ganapathy A; Penland RL; Chévez-Barrios P
    Arch Pathol Lab Med; 2015 Dec; 139(12):1531-8. PubMed ID: 26619025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer stem cell characteristics in retinoblastoma.
    Seigel GM; Campbell LM; Narayan M; Gonzalez-Fernandez F
    Mol Vis; 2005 Sep; 11():729-37. PubMed ID: 16179903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.
    Stitt AW; Simpson DA; Boocock C; Gardiner TA; Murphy GM; Archer DB
    J Pathol; 1998 Nov; 186(3):306-12. PubMed ID: 10211121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic characterization of retinoblastoma for the presence of putative cancer stem-like cell markers by flow cytometry.
    Balla MM; Vemuganti GK; Kannabiran C; Honavar SG; Murthy R
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1506-14. PubMed ID: 19029022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irresponsiveness of two retinoblastoma cases to conservative therapy correlates with up- regulation of hERG1 channels and of the VEGF-A pathway.
    Fortunato P; Pillozzi S; Tamburini A; Pollazzi L; Franchi A; La Torre A; Arcangeli A
    BMC Cancer; 2010 Sep; 10():504. PubMed ID: 20860824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human embryonic and neuronal stem cell markers in retinoblastoma.
    Seigel GM; Hackam AS; Ganguly A; Mandell LM; Gonzalez-Fernandez F
    Mol Vis; 2007 Jun; 13():823-32. PubMed ID: 17615543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy.
    Ding XW; Wu JH; Jiang CP
    Life Sci; 2010 Apr; 86(17-18):631-7. PubMed ID: 20159023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-induced lncRNA ANRIL promotes cisplatin resistance in retinoblastoma cells through regulating ABCG2 expression.
    Yin X; Liao Y; Xiong W; Zhang Y; Zhou Y; Yang Y
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1049-1057. PubMed ID: 32173903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro study on expression of tumor stem cell biomarker and transdifferentiation towards endothelial cells of retinoblastoma cells under hypoxia condition].
    Zhang LN; Zhao GQ; Wang Q; Niu YJ; Xu Q; Yang WY
    Zhonghua Yan Ke Za Zhi; 2013 Aug; 49(8):736-43. PubMed ID: 24246814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of p27(KIP1) in the developing retina and retinoblastoma.
    Kase S; Yoshida K; Nakayama KI; Nakayama K; Ikeda H; Harada T; Harada C; Ohgami K; Shiratori K; Ohno S
    Int J Mol Med; 2005 Aug; 16(2):257-62. PubMed ID: 16012758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases.
    Pe'er J; Shweiki D; Itin A; Hemo I; Gnessin H; Keshet E
    Lab Invest; 1995 Jun; 72(6):638-45. PubMed ID: 7540233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathologic features of retinoblastoma and expression of VEGF and Ki-67 after comprehensive treatment].
    Xue K; Qian J; Bi YW; Yao YQ; Yuan YF; DA CD
    Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):134-41. PubMed ID: 21426843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leucine-Rich α-2-Glycoprotein-1 (LRG-1) Expression in Retinoblastoma.
    Amer R; Tiosano L; Pe'er J
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):685-692. PubMed ID: 29392314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parvalbumin, a horizontal cell-associated calcium-binding protein in retinoblastoma eyes.
    Kivelä T
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):1044-8. PubMed ID: 9579485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Stem Cells with Overexpression of Neuronal Markers Enhance Chemoresistance and Invasion in Retinoblastoma.
    Balaji S; Santhi R; Kim U; Muthukkaruppan V; Priya CG; Vanniarajan A
    Curr Cancer Drug Targets; 2020; 20(9):710-719. PubMed ID: 32364077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HIF-1alpha, HPSE and VEGF promote malignant progression of retinoblastoma].
    Wang XL; Niu YJ; Ma JM
    Zhonghua Yan Ke Za Zhi; 2010 Feb; 46(2):140-4. PubMed ID: 20388348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of vascular endothelial growth factor (VEGF) in retinoblastoma but not in posterior uveal melanoma.
    Kvanta A; Steen B; Seregard S
    Exp Eye Res; 1996 Nov; 63(5):511-8. PubMed ID: 8994354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential CRX and OTX2 expression in human retina and retinoblastoma.
    Glubrecht DD; Kim JH; Russell L; Bamforth JS; Godbout R
    J Neurochem; 2009 Oct; 111(1):250-63. PubMed ID: 19686387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.